Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 227 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Woman Showed Up To Their Wedding And Stole All Their Gifts.... March 11, 2019 ‘Will cancer make me infertile?’ – That Cancer Conversation May 12, 2021 The Benefits of Yoga During Cancer and How to Get Started August 2, 2022 Rediscovered Drugs Hit Leukemia from Two Different Angles July 21, 2020 Load more HOT NEWS Cancer vaccines – where are we? EMA Recommends Granting a Marketing Authorisation for Tislelizumab Giving Birth Before Age 20 Cuts Breast Risk By 50%, And... Germline Pathogenic Variants in CDH1, BRCA2, CHEK2, ATM, and PALB2 Associated...
